Justin Bowers
Stock Analyst at Wells Fargo
(1.92)
# 3,228
Out of 5,090 analysts
42
Total ratings
40%
Success rate
4.5%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FLUT Flutter Entertainment | Initiates: Overweight | $272 | $208.50 | +30.46% | 1 | Nov 18, 2025 | |
| DKNG DraftKings | Initiates: Equal-Weight | $31 | $34.00 | -8.82% | 1 | Nov 18, 2025 | |
| WAT Waters | Maintains: Hold | $375 → $315 | $394.81 | -20.21% | 4 | Aug 5, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $270 → $430 | $548.12 | -21.55% | 3 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $225.85 | +17.33% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $14.24 | +61.52% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $19.47 | +48.95% | 1 | Aug 19, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $17.77 | +40.69% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $164.98 | -6.05% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $572.77 | +6.50% | 3 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $82 | $61.68 | +32.94% | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $10.93 | +128.73% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $3.70 | +359.46% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $185.80 | +61.46% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $226.25 | +21.55% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $280.23 | -10.79% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $184.31 | +57.34% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $14.91 | +208.52% | 5 | May 10, 2021 |
Flutter Entertainment
Nov 18, 2025
Initiates: Overweight
Price Target: $272
Current: $208.50
Upside: +30.46%
DraftKings
Nov 18, 2025
Initiates: Equal-Weight
Price Target: $31
Current: $34.00
Upside: -8.82%
Waters
Aug 5, 2025
Maintains: Hold
Price Target: $375 → $315
Current: $394.81
Upside: -20.21%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $270 → $430
Current: $548.12
Upside: -21.55%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $225.85
Upside: +17.33%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $14.24
Upside: +61.52%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $19.47
Upside: +48.95%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $17.77
Upside: +40.69%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $164.98
Upside: -6.05%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $572.77
Upside: +6.50%
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $61.68
Upside: +32.94%
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $10.93
Upside: +128.73%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $3.70
Upside: +359.46%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $185.80
Upside: +61.46%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $226.25
Upside: +21.55%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $280.23
Upside: -10.79%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $184.31
Upside: +57.34%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $14.91
Upside: +208.52%